Table 1. Patients and pleural fluid characteristics .
| Patients | 45 (100%) |
| Age | 60.8±15.9 |
| Male | 17 (37.7%) |
| Female | 28 (62.2%) |
| Comorbidities | |
|
Systemic hypertension Ave. LVEF% |
14 (31.1%) 57.5%±6.5 |
| Pleural fluid | |
| Pleural fluid volume, mL | 1171±635 |
|
Left Right |
20 (44.4%) 25 (55.5%) |
| Fluid LDH, IU/L-1 | 659 ±643 |
| Fluid protein, mg/dL | 3.36 ±1.4 |
| Neutrophil/Leucocyte ratio | 9.76±20.5 |
| Malignancy | |
|
Lung Breast Metastatic Esoph/Gastric Lymphoma Ginecological Mesothelioma |
13 (28.8%) 10 (22.2%) 9 (20%) 5 (11.1%) 4 (8.8%) 3 (6.6%) 1 (2.2%) |
| Pre-op ECOG | 3±0.9 |
|
Pre-op LENT score Low risk (0-1) Moderate risk (2-4) High risk (5-7) Average |
1 (2.2%) 31 (68.8%) 13 (28.8%) 3.95±1.2 |
| Total | 45 (100%) |
Abbreviations: LVEF, left ventricular ejection fraction; LDH, Lactate dehydrogenase; ECOG, Eastern Cooperative Oncology Group; LENT, Lactate, ECOG, Neutrophil-Lymphocyte ratio, Tumor type